Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Exercise can counter detrimental effects of cancer treatment, review suggests

2.

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

3.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

4.

Radiotherapy after mastectomy can be avoided, study finds

5.

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot